Gastrointestinal hormones and food intake

Gastroenterology

Volumn 128, Issue 1, 2005, Pages 175-191

  Strader, April D ^a   Woods, Stephen C ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; APOLIPOPROTEIN A4; BOMBESIN; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; ENTEROSTATIN; GASTRIN; GASTROINTESTINAL HORMONE; GHRELIN; GLICENTIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; LEPTIN; OXYNTOMODULIN; PEPTIDE YY;

ARTICLE; BYPASS SURGERY; FOOD INTAKE; GASTROINTESTINAL TRACT; HOMEOSTASIS; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; KNOCKOUT MOUSE; MEDICAL LITERATURE; MUTATION; NERVE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INTERACTION; SATIETY; SIGNAL TRANSDUCTION; STOMACH SURGERY; VAGUS NERVE;

EID: 11144338712     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.10.043     Document Type: Article

References (276)

1. S.C. Woods, R.J. Seeley, D.J. Porte, M.W. Schwartz Signals that regulate food intake and energy homeostasis Science 280 1998 1378 1383
2. S.C. Woods, M.W. Schwartz, D.G. Baskin, R.J. Seeley Food intake and the regulation of body weight Annu Rev Psychol 51 2000 255 277
3. M.W. Schwartz, S.C. Woods, D.J. Porte, R.J. Seeley, D.G. Baskin Central nervous system control of food intake Nature 404 2000 661 671
4. R.J. Seeley, S.C. Woods Monitoring of stored and available fuel by the CNS implications for obesity Nat Rev Neurosci 4 2003 901 909
5. S.C. Woods Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake Am J Physiol 286 2004 G7 G13
6. W.M. Bayliss, E.H. Starling The mechanism of pancreatic secretion J Physiol 28 1902 325
7. J.S. Edkins On the chemical mechanism of gastric acid secretion Proc R Soc Lond B Biol Sci 76 1905 376 390
8. J.E. Jorpes, V. Mutt Secretin, pancreozymin, and cholecystokinin their preparation and properties Gastroenterology 36 1959 377 385
9. P.C. Emson, S.P. Hunt, J.F. Rehfeld, N. Golterman, J. Fahrenkrug Cholecystokinin and vasoactive intestinal polypeptide in the mammalian CNS distribution and possible physiological roles Adv Biochem Psychopharmacol 22 1980 63 74
10. M. Adamo, M.K. Raizada, D. LeRoith Insulin and insulin-like growth factor receptors in the nervous system Mol Neurobiol 3 1989 71 100
11. D.P. Figlewicz, F. Lacour, A. Sipols, D. Porte Jr, S.C. Woods Gastro-enteropancreatic (GEP) peptides and the central nervous system Ann Rev Physiol 49 1987 383 395
12. T.H. Moran, E.E. Ladenheim, G.J. Schwartz Within-meal gut feedback signaling Int J Obes Relat Metab Dis 25 Suppl 5 2001 S39 S41
13. T.H. Moran, K.P. Kinzig Gastrointestinal satiety signals II. Cholecystokinin Am J Physiol 286 2004 G183 G188
14. J. Antin, J. Gibbs, J. Holt, R.C. Young, G.P. Smith Cholecystokinin elicits the complete behavioral sequence of satiety in rats J Comp Physiol Psychol 89 1975 784 790
15. G.P. Smith, J. Gibbs The development and proof of the cholecystokinin hypothesis of satiety C.T. Dourish S.J. Cooper S.D. Iversen L.L. Iversen Multiple cholecystokinin receptors in the CNS 1992 Oxford University Press Oxford 166 182
16. J.H. Strubbe, G. van Dijk The temporal organization of ingestive behaviour and its interaction with regulation of energy balance Neurosci Biobehav Rev 26 2002 485 498
17. H.R. Kissileff, F.X. Pi-Sunyer, J. Thornton, G.P. Smith Cholecystokinin decreases food intake in man Am J Clin Nutr 34 1981 154 160
18. N.E. Muurahainen, H.R. Kissileff, F.X. Pi-Sunyer Intravenous infusion of bombesin reduces food intake in humans Am J Physiol 264 1993 R350 R354
19. N. Muurahainenn, H.R. Kissileff, A.J. Derogatis, F.X. Pi-Sunyer Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man Physiol Behav 44 1988 644 649
20. X. Pi-Sunyer, H.R. Kissileff, J. Thornton, G.P. Smith C-terminal octapeptide of cholecystokinin decreases food intake in obese men Physiol Behav 29 1982 627 630
21. D.E. Cummings, M.H. Shannon Roles for ghrelin in the regulation of appetite and body weight Arch Surg 138 2003 389 396
22. M. Tschöp, D.L. Smiley, M.L. Heiman Ghrelin induces adiposity in rodents Nature 407 2000 908 913
23. K.A. Roth, J.I. Gordon Spatial differentiation of the intestinal epithelium analysis of enteroendocrine cells containing immunoreactive serotonin, secretin, and substance P in normal and transgenic mice Proc Natl Acad Sci U S A 87 1990 6408 6412
24. O. Lundgren Interface between the intestinal environment and the nervous system Gut 53 Suppl 2 2004 16 18
25. N. Mei Intestinal chemosensitivity Physiol Rev 65 1985 211 237
26. N. Read, S. French, K. Cunningham The role of the gut in regulating food intake in man Nutr Rev 52 1994 1 10
27. H.E. Raybould Nutrient tasting and signaling mechanisms in the gut. I. Sensing of lipid by the intestinal mucosa Am J Physiol 277 1999 G751 G755
28. J.N. Roberge, P.L. Brubaker Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients Endocrinology 128 1991 3169 3174
29. P. Tso, Q. Chen, K. Fujimoto, K. Fukagawa, T. Sakata Apolipoprotein A-IV a circulating satiety signal produced by the small intestine Obes Res 3 Suppl 5 1995 S689 S695
30. P. Layer, J.J. Holst, D. Grandt, H. Goebell Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans Dig Dis Sci 40 1995 1074 1082
31. L. Pironi, V. Stanghellini, M. Miglioli, R. Corinaldesi, R. De Giorgio, E. Ruggeri, C. Tosetti, G. Poggioli, A.M. Morselli Labate, N. Monetti Fat-induced ileal brake in humans a dose-dependent phenomenon correlated to the plasma levels of peptide YY Gastroenterology 105 1993 733 739
32. Q. Xiao, R.P. Boushey, D.J. Drucker, P.L. Brubaker Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans (comments) Gastroenterology 117 1999 99 105
33. P. Holzer, T. Michl, M. Danzer, M. Jocic, R. Schicho, I.T. Lippe Surveillance of the gastrointestinal mucosa by sensory neurons J Physiol Pharmacol 52 2001 505 521
34. R.D. Reidelberger Cholecystokinin and control of food intake J Nutr 124 1994 S1327 S1333
35. B. Beck Gastric inhibitory polypeptide a gut hormone with anabolic functions J Mol Endocrinol 2 1989 169 174
36. R.A. Liddle, I.D. Goldfine, M.S. Rosen, R.A. Taplitz, J.A. Williams Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction J Clin Invest 75 1985 1144 1152
37. W.Y. Chey, T. Chang Neural hormonal regulation of exocrine pancreatic secretion Pancreatology 1 2001 320 335
38. P.L. Brubaker, A. Izzo, M. Hill, D.J. Drucker Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2 Am J Physiol 272 1997 E1050 E1058
39. M. Buyse, T. Aparicio, S. Guilmeau, H. Goiot, I. Sobhani, A. Bado Paracrine actions of the stomach-derived leptin Med Sci (Paris) 20 2004 183 188
40. G.E. Holle, J. Dietl, I. Demir Influence of the intramural innervation on the morphogenesis of the enteroendocrine cells and the genetic construct involved (review) Int J Mol Med 11 2003 275 285
41. T.H. Moran, R. Norgren, R.J. Crosby, P.R. McHugh Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers Brain Res 526 1990 95 102
42. L. Rinaman, G.E. Hoffman, J. Dohanics, W.W. Le, E.M. Stricker, J.G. Verbalis Cholecystokinin activates catecholaminergic neurons in the caudal medulla that innervate the paraventricular nucleus of the hypothalamus in rats J Comp Neurol 360 1995 246 256
43. H.J. Grill, G.P. Smith Cholecystokinin decreases sucrose intake in chronic decerebrate rats Am J Physiol 254 1988 R853 R856
44. H.J. Grill, J.M. Kaplan The neuroanatomical axis for control of energy balance Front Neuroendocrinol 23 2002 2 40
45. R.J. Seeley, H.J. Grill, J.M. Kaplan Neurological dissociation of gastrointestinal and metabolic contributions to meal size control Behav Neurosci 108 1994 347 352
46. H.R. Berthoud Multiple neural systems controlling food intake and body weight Neurosci Biobehav Rev 26 2002 393 428
47. T.L. Powley, R.J. Phillips Musings on the wanderer: what's new in our understanding of vago-vagal reflexes? I. Morphology and topography of vagal afferents innervating the GI tract Am J Physiol Gastrointest Liver Physiol 283 2002 G1217 G1225
48. J.A. Deutsch The role of the stomach in eating Am J Clin Nutr 42 1985 1040 1043
49. R.J. Phillips, T.L. Powley Gastric volume rather than nutrient content inhibits food intake Am J Physiol 271 1996 R766 R769
50. J.S. Davison, G.D. Clarke Mechanical properties and sensitivity to CCK of vagal gastric slowly adapting mechanoreceptors Am J Physiol 255 1988 G55 G61
51. J.M. Kaplan, T.H. Moran Gastrointestinal signaling in the control of food intake E.M. Stricker S.C. Woods 2nd edition Handbook of behavioral neurobiology. Neurobiology of food and fluid intake Volume 14 2004 Kluwer Academic New York 275-305
52. J.M. Polak, S.R. Bloom, P.L. Rayford, A.G. Pearse, A.M. Buchan, J.C. Thompson Identification of cholecystokinin-secreting cells Lancet 2 1975 1016 1018
53. M.C. Beinfeld, D.K. Meyer, M.J. Brownstein Cholecystokinin in the central nervous system Peptides 2 Suppl 2 1981 77 79
54. S.A. Wank, R. Harkins, R.T. Jensen, H. Shapira, A. de Weerth, T. Slattery Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas Proc Natl Acad Sci U S A 89 1992 3125 3129
55. S.A. Wank, J.R. Pisegna, A. de Weerth Brain and gastrointestinal cholecystokinin receptor family structure and functional expression Proc Natl Acad Sci U S A 89 1992 8691 8695
56. T.H. Moran, P.H. Robinson, M.S. Goldrich, P.R. McHugh Two brain cholecystokinin receptors implications for behavioral actions Brain Res 362 1986 175 179
57. R. Herranz Cholecystokinin antagonists pharmacological and therapeutic potential Med Res Rev 23 2003 559 605
58. B.R. Douglas, J.B. Jansen, A.J. de Jong, C.B. Lamers Effect of various triglycerides on plasma cholecystokinin levels in rats J Nutr 120 1990 686 690
59. L.D. Lewis, J.A. Williams Regulation of cholecystokinin secretion by food, hormones, and neural pathways in the rat Am J Physiol 258 1990 G512 G518
60. G.J. Schwartz, T.H. Moran, W.O. White, E.E. Ladenheim Relationships between gastric motility and gastric vagal afferent responses to CCK and GRP in rats differ Am J Physiol 272 1997 R1726 R1733
61. J.R. Grider Role of cholecystokinin in the regulation of gastrointestinal motility J Nutr 124 1994 1334S 1339S
62. J. Gibbs, R.C. Young, G.P. Smith Cholecystokinin decreases food intake in rats J Comp Physiol Psychol 84 1973 488 495
63. D.P. Figlewicz, L.J. Stein, D. West, D. Porte Jr, S.C. Woods Intracisternal insulin alters sensitivity to CCK-induced meal suppression in baboons Am J Physiol 250 1986 R856 R860
64. D.M. Zhang, W. Bula, E. Stellar Brain cholecystokinin as a satiety peptide Physiol Behav 36 1986 1183 1186
65. M.A. Della-Fera, C.A. Baile CCK-octapeptide injected in CSF decreases meal size and daily food intake in sheep Peptides 1 1980 51 54
66. T.R. Houpt The sites of action of cholecystokinin in decreasing meal size in pigs Physiol Behav 31 1983 693 698
67. H.R. Kissileff, F.X. Pi-Sunyer, J. Thornton, G.P. Smith C-terminal octapeptide of cholecystokinin decreases food intake in man Am J Clin Nutr 34 1981 154 160
68. N. Snapir, Z. Glick Cholecystokinin and meal size in the domestic fowl Physiol Behav 21 1978 1051 1052
69. J. Gibbs, G.P. Smith Cholecystokinin and satiety in rats and rhesus monkeys Am J Clin Nutr 30 1977 758 761
70. D.P. Figlewicz, A.J. Sipols, P. Green, D. Porte Jr, S.C. Woods IVT CCK-8 is more effective than IV CCK-8 in decreasing meal size in the baboon Brain Res Bull 22 1989 849 852
71. C. Beglinger, L. Degen, D. Matzinger, M. D'Amato, J. Drewe Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans Am J Physiol 280 2001 R1149 R1154
72. G. Hewson, G.E. Leighton, R.G. Hill, J. Hughes The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of endogenous cholecystokinin Br J Pharmacol 93 1988 79 84
73. T.H. Moran, P.J. Ameglio, H.J. Peyton, G.J. Schwartz, P.R. McHugh Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys Am J Physiol 265 1993 R620 R624
74. R.D. Reidelberger, M.F. O'Rourke Potent cholecystokinin antagonist L-364,718 stimulates food intake in rats Am J Physiol 257 1989 R1512 R1518
75. J.N. Crawley, M.C. Beinfeld Rapid development of tolerance to the behavioural actions of cholecystokinin Nature 302 1983 703 706
76. D.B. West, D. Fey, S.C. Woods Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats Am J Physiol 246 1984 R776 R787
77. D.B. West, M.R.C. Greenwood, K.A. Marshall, S.C. Woods Lithium chloride, cholecystokinin and meal patterns evidence the cholecystokinin suppresses meal size in rats without causing malaise Appetite 8 1987 221 227
78. Y. Tsunoda, H. Yao, J. Park, C. Owyang Cholecystokinin synthesizes and secretes leptin in isolated canine gastric chief cells Biochem Biophys Res Commun 310 2003 681 684
79. M.D. Barrachina, V. Martinez, L. Wang, J.Y. Wei, Y. Tache Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice Proc Natl Acad Sci U S A 94 1997 10455 10460
80. C.A. Matson, D.F. Reid, T.A. Cannon, R.C. Ritter Cholecystokinin and leptin act synergistically to reduce body weight Am J Physiol 278 2000 R882 R890
81. C.A. Matson, M.F. Wiater, J.L. Kuijper, D.S. Weigle Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake Peptides 18 1997 1275 1278
82. M. Emond, G.J. Schwartz, E.E. Ladenheim, T.H. Moran Central leptin modulates behavioral and neural responsivity to CCK Am J Physiol 276 1999 R1545 R1549
83. D.P. Figlewicz, A.J. Sipols, R.J. Seeley, M. Chavez, S.C. Woods, D.J. Porte Intraventricular insulin enhances the meal-suppressive efficacy of intraventricular cholecystokinin octapeptide in the baboon Behav Neurosci 109 1995 567 569
84. C.A. Riedy, M. Chavez, D.P. Figlewicz, S.C. Woods Central insulin enhances sensitivity to cholecystokinin Physiol Behav 58 1995 755 760
85. K.D. Niswender, M.W. Schwartz Insulin and leptin revisited adiposity signals with overlapping physiological and intracellular signaling capabilities Front Neuroendocrinol 24 2003 1 10
86. P.J. Kulkosky, C. Breckenridge, R. Krinsky, S.C. Woods Satiety elicited by the C-terminal octapeptide of cholecystokinin-pancreozymin in normal and VMH-lesioned rats Behav Biol 18 1976 227 234
87. A.B. Moos, C.L. McLaughlin, C.A. Baile Effects of CCK on gastrointestinal function in lean and obese Zucker rats Peptides 3 1982 619 622
88. A. Funakoshi, K. Miyasaka, H. Shinozaki, M. Masuda, T. Kawanami, Y. Takata, A. Kono An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor Bichem Biophys Res Commun 210 1995 787 796
89. S. Bi, T.H. Moran Actions of CCK in the controls of food intake and body weight lessons from the CCK-A receptor deficient OLETF rat Neuropeptides 36 2002 171 181
90. T.H. Moran, L.F. Katz, C.R. Plata-Salaman, G.J. Schwartz Disordered food intake and obesity in rats lacking cholecystokinin A receptors Am J Physiol 274 1998 R618 R625
91. D.N. Lorenz, S.A. Goldman Vagal mediation of the cholecystokinin satiety effect in rats Physiol Behav 29 1982 599 604
92. T.H. Moran, A.R. Baldessarini, C.F. Salorio, T. Lowery, G.J. Schwartz Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin Am J Physiol 272 1997 R1245 R1251
93. G.L. Edwards, E.E. Ladenheim, R.C. Ritter Dorsomedial hindbrain participation in cholecystokinin-induced satiety Am J Physiol 251 1986 R971 R977
94. W. Fan, K.L. Ellacott, I.G. Halatchev, K. Takahashi, P. Yu, R.D. Cone Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system Nat Neurosci 7 2004 335 336
95. J. Gibbs, D.J. Fauser, E.A. Rowe, E.T. Rolls, S.P. Maddison Bombesin suppresses feeding in rats Nature 282 1979 208 210
96. J. Gibbs, J.L. Guss Bombesin-like peptides and satiety Appetite 24 1995 257
97. E.E. Ladenheim, K.E. Wirth, T.H. Moran Receptor subtype mediation of feeding suppression by bombesin-like peptides Pharmacol Biochem Behav 54 1996 705 711
98. L.J. Stein, S.C. Woods Gastrin releasing peptide reduces meal size in rats Peptides 3 1982 833 835
99. E.E. Ladenheim, R.T. Jensen, S.A. Mantey, T.H. Moran Distinct distributions of two bombesin receptor subtypes in the rat central nervous system Brain Res 593 1992 168 178
100. N. Minamino, K. Kangawa, H. Matsuo Neuromedin B a novel bombesin-like peptide identified in porcine spinal cord Biochem Biophys Res Commun 114 1983 541 548
101. E.E. Ladenheim, J.E. Taylor, D.H. Coy, T.S. Carrigan, A. Wohn, T.H. Moran Caudal hindbrain neuromedin B-preferring receptors participate in the control of food intake Am J Physiol 272 1997 R433 R437
102. E.E. Ladenheim, L.L. Hampton, A.C. Whitney, W.O. White, J.F. Battey, T.H. Moran Disruptions in feeding and body weight control in gastrin-releasing peptide receptor deficient mice J Endocrinol 174 2002 273 281
103. J. Miesner, G.P. Smith, J. Gibbs, A. Tyrka Intravenous infusion of CCKA-receptor antagonist increases food intake in rats Am J Physiol 262 1992 R216 R219
104. P.A. Rushing, J. Gibbs, N. Geary Brief, meal-contingent infusions of gastrin-releasing peptide 1-27 and neuromedin B-10 in spontaneous feeding in rats Physiol Behav 60 1996 1501 1504
105. P.A. Rushing, J. Gibbs Prolongation of intermeal interval by gastrin-releasing peptide depends upon time of delivery Peptides 19 1998 1439 1442
106. P.A. Rushing, R.P. Henderson, J. Gibbs Prolongation of the postprandial intermeal interval by gastrin-releasing peptide 1-27 in spontaneously feeding rats Peptides 19 1998 175 177
107. J.A. Stuckey, J. Gibbs, G.P. Smith Neural disconnection of gut from brain blocks bombesin-induced satiety Peptides 6 1985 1249 1252
108. A.K. Thaw, J.C. Smith, J. Gibbs Mammalian bombesin-like peptides extend the intermeal interval in freely feeding rats Physiol Behav 64 1998 425 428
109. B. Ludvik, A. Kautzky-Willer, R. Prager, K. Thomaseth, G. Pacini Amylin history and overview Diabetic Med 14 Suppl 2 1997 S9 S13
110. W.T. Chance, A. Balasubramaniam, F.S. Zhang, S.J. Wimalawansa, J.E. Fischer Anorexia following the intrahypothalamic administration of amylin Brain Res 539 1991 352 354
111. T.A. Lutz, E. Del Prete, E. Scharrer Reduction of food intake in rats by intraperitoneal injection of low doses of amylin Physiol Behav 55 1994 891 895
112. T.A. Lutz, N. Geary, M.M. Szabady, E. Del Prete, E. Scharrer Amylin decreases meal size in rats Physiol Behav 58 1995 1197 1202
113. P.A. Rushing, M.M. Hagan, R.J. Seeley, T.A. Lutz, S.C. Woods Amylin a novel action in the brain to reduce body weight Endocrinology 141 2000 850 853
114. T.A. Lutz, J. Althaus, R. Rossi, E. Scharrer Anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibers Am J Physiol 274 1998 R1777 R1782
115. T.A. Lutz, M. Senn, J. Althaus, E. Del Prete, F. Ehrensperger, E. Scharrer Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats Peptides 19 1998 309 317
116. T.A. Lutz, E. Del Prete, E. Scharrer Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin Peptides 16 1995 457 462
117. P.A. Rushing, T.A. Lutz, R.J. Seeley, S.C. Woods Amylin and insulin interact to reduce food intake in rats Horm Metab Res 32 2000 62 65
118. J.J. Holst Enteroglucagon Annu Rev Physiol 59 1997 257 271
119. D.A. D'Alessio, S.E. Kahn, C.R. Leusner, J.W. Ensinck Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal J Clin Invest 99 1994 2263 2266
120. D. D'Alessio Peptide hormone regulation of islet cells Horm Metab Res 29 1997 297 300
121. D.J. Drucker Biological actions and therapeutic potential of the glucagon-like peptides Gastroenterology 122 2002 531 544
122. C. Hermann, R. Goke, G. Richter, H.C. Fehman, R. Arnbold, B. Goke Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients Digestion 56 1995 117 126
123. T.J. Kieffer, C.H. McIntosh, R.A. Pederson Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV Endocrinology 136 1995 3585 3596
124. R.V. Campos, Y.C. Lee, D.J. Drucker Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse Endocrinology 134 1994 2156 2164
125. P.L. Brubaker, Y. Anini Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2 Can J Physiol Pharmacol 81 2003 1005 1012
126. C. Qualmann, M.A. Nauck, J.J. Holst, C. Orskov, W. Creutzfeldt Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose) Scand J Gastroenterol 30 1995 892 896
127. M. Giralt, P. Vergara Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat Dig Dis Sci 44 1999 322 329
128. M.A. Nauck, U. Niedereichholz, R. Ettler, J.J. Holst, C. Orskov, R. Ritzel, W.H. Schmiegel Glucagon-like peptide-1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans (comments) Am Physiol Soc 1997 E981 E988
129. M.D. Turton, D. O'Shea, I. Gunn, S.A. Beak, C.M. Edwards, K. Meeran, S.J. Choi, G.M. Taylor, M.M. Heath, P.D. Lambert, J.P. Wilding, D.M. Smith, M.A. Ghatei, J. Herbert, S.R. Bloom A role for glucagon-like peptide-1 in the central regulation of feeding (comments) Nature 379 1996 69 72
130. M. Tang-Christensen, P.J. Larsen, R. Goke, A. Fink-Jensen, D.S. Jessop, M. Moller, S.P. Sheikh Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats Am J Physiol 271 1996 R848 R856
131. J.C. Donahey, G. van Dijk, S.C. Woods, R.J. Seeley Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats Brain Res 779 1998 75 83
132. E. Naslund, M. Gutniak, S. Skogar, S. Rossner, P.M. Hellstrom Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men Am J Clin Nutr 68 1998 525 530
133. J.P. Gutzwiller, B. Goke, J. Drewe, P. Hildebrand, S. Ketterer, D. Handschin, R. Winterhalder, D. Conen, C. Beglinger Glucagon-like peptide-1 a potent regulator of food intake in humans Gut 44 1999 81 86
134. T.E. Thiele, G. Van Dijk, L.A. Campfield, F.J. Smith, P. Burn, S.C. Woods, I.L. Bernstein, R.J. Seeley Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats Am J Physiol 272 1997 R726 R730
135. G. van Dijk, T.E. Thiele, J.C.K. Donahey, L.A. Campfield, F.J. Smith, P. Burn, I.L. Bernstein, S.C. Woods, R.J. Seeley Central infusion of leptin and GLP-1-(7-36) amide differentially stimulate c-Fos-like immunoreactivity in the rat brain Am J Physiol 271 1996 R1096 R1100
136. P.J. Shughrue, M.V. Lane, I. Merchenthaler Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus Endocrinology 137 1996 5159 5162
137. M. Navarro, F. Rodriquez de Fonseca, E. Alvarez, J.A. Chowen, J.A. Zueco, R. Gomez, J. Eng, E. Blazquez Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake J Neurochem 67 1996 1982 1991
138. J.J. Hwa, L. Ghibaudi, P. Williams, M.B. Witten, R. Tedesco, C.D. Strader Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation Peptides 19 1998 869 875
139. M. Tang-Christensen, P.J. Larsen, R. Goke, A. Fink-Jensen, D.S. Jessop, M. Moller, S.P. Sheikh Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats Am J Physiol 271 1996 R848 R856
140. M. Tang-Christensen, N. Vrang, P.J. Larsen Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment Diabetes 47 1998 530 537
141. K.P. Kinzig, D.A. D'Alessio, R.J. Seeley The diverse roles of CNS GLP-1 in the control of food intake and the mediation of visceral illness J Neurosci 22 2002 10470 10476
142. P.J. Larsen, M. Tang-Christensen, D.S. Jessop Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat Endocrinology 138 1997 4445 4455
143. L.R. McMahon, P.J. Wellman Decreased intake of a liquid diet in nonfood-deprived rats following intra-PVN injections of GLP-1 (7-36) amide Pharmacol Biochem Behav 58 1997 673 677
144. L.R. McMahon, P.J. Wellman PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats Am J Physiol 274 1998 R23 R29
145. L. Rinaman A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia Am J Physiol 277 1999 R1537 R1540
146. G. van Dijk, T.E. Thiele, R.J. Seeley, S.C. Woods, I.L. Bernstein Glucagon-like peptide-1 and satiety? Nature 385 1997 214
147. K.P. Kinzig, D.A. D'Alessio, J.P. Herman, R.R. Sakai, T.P. Vahl, H.F. Figueredo, E.K. Murphy, R.J. Seeley CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors J Neurosci 23 2003 6163 6170
148. E. Naslund, B. Barkeling, N. King, M. Gutniak, J.E. Blundell, J.J. Holst, S. Rossner, P.M. Hellstrom Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men Int J Obes Relat Metab Disord 23 1999 304 311
149. M.B. Toft-Nielsen, S. Madsbad, J.J. Holst Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients Diabetes Care 22 1999 1137 1143
150. J.P. Gutzwiller, J. Drewe, B. Goke, H. Schmidt, B. Rohrer, J. Lareida, C. Beglinger Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2 Am J Physiol 276 1999 R1541 R1544
151. S. Delgado-Aros, D.Y. Kim, D.D. Burton, G.M. Thomforde, D. Stephens, B.H. Brinkmann, A. Vella, M. Camilleri Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans Am J Physiol 282 2002 G424 G431
152. A.J. Kastin, V. Akerstrom, W. Pan Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier J Mol Neurosci 18 2002 7 14
153. P.J. Larsen, N. Vrang, M. Tang-Christensen Central pre-proglucagon derived peptides opportunities for treatment of obesity Curr Pharm Des 9 2003 1373 1382
154. M.A. Nauck Glucagon-like peptide 1 (GLP-1) a potent gut hormone with a possible therapeutic perspective Acta Diabetol 35 1998 117 129
155. J. Eng, W.A. Kleinman, L. Singh, G. Singh, J.P. Raufman Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas J Biol Chem 267 1992 7402 7405
156. M. Pohl, S.A. Wank Molecular cloning of the helodermin and exendin-4 cDNAs in the lizard. Relationship to vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide and glucagon-like peptide 1 and evidence against the existence of mammalian homologues J Biol Chem 273 1998 9778 9784
157. R. Goke, H.C. Fehmann, T. Linn, H. Schmidt, M. Krause, J. Eng, B. Goke Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cells J Biol Chem 268 1993 19650 19655
158. C.M. Edwards, S.A. Stanley, R. Davis, A.E. Brynes, G.S. Frost, L.J. Seal, M.A. Ghatei, S.R. Bloom Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers Am J Physiol Endocrinol Metab 281 2001 E155 E161
159. O.G. Kolterman, J.B. Buse, M.S. Fineman, E. Gaines, S. Heintz, T.A. Bicsak, K. Taylor, D. Kim, M. Aisporna, Y. Wang, A.D. Baron Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes J Clin Endocrinol Metab 88 2003 3082 3089
160. M. Szayna, M.E. Doyle, J.A. Betkey, H.W. Holloway, R.G. Spencer, N.H. Greig, J.M. Egan Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats Endocrinology 141 2000 1936 1941
161. K.A. Al-Barazanji, J.R. Arch, R.E. Buckingham, M. Tadayyon Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats (In Process Citation) Obes Res 8 2000 317 323
162. P. Kirkegaard, A.J. Moody, J.J. Holst, F.B. Loud, P.S. Olsen, J. Christiansen Glicentin inhibits gastric acid secretion in the rat Nature 297 1982 156 157
163. C.L. Dakin, I. Gunn, C.J. Small, C.M. Edwards, D.L. Hay, D.M. Smith, M.A. Ghatei, S.R. Bloom Oxyntomodulin inhibits food intake in the rat Endocrinology 142 2001 4244 4250
164. C.L. Dakin, C.J. Small, A.J. Park, A. Seth, M.A. Ghatei, S.R. Bloom Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats Am J Physiol Endocrinol Metab 283 2002 E1173 E1177
165. M.A. Cohen, S.M. Ellis, C.W. Le Roux, R.L. Batterham, A. Park, M. Patterson, G.S. Frost, M.A. Ghatei, S.R. Bloom Oxyntomodulin suppresses appetite and reduces food intake in humans J Clin Endocrinol Metab 88 2003 4696 4701
166. D.J. Drucker Glucagon-like peptide 2 Trends Endocrinol Metab 10 1999 153 156
167. P.B. Jeppesen Clinical significance of GLP-2 in short-bowel syndrome J Nutr 133 2003 3721 3724
168. B.W. Warner GLP-2 as therapy for the short-bowel syndrome Gastroenterology 120 2001 1041 1043
169. C. Orskov, J.J. Holst, S. Knuhtsen, F.G. Baldissera, S.S. Poulsen, O.V. Nielsen Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas Endocrinology 119 1986 1467 1475
170. M. Tang-Christensen, P.J. Larsen, J. Thulesen, J. Romer, N. Vrang The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake Nat Med 6 2000 802 807
171. L.B. Sorensen, A. Flint, A. Raben, B. Hartmann, J.J. Holst, A. Astrup No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects Int J Obes Relat Metab Disord 27 2003 450 456
172. P.T. Schmidt, E. Naslund, P. Gryback, H. Jacobsson, B. Hartmann, J.J. Holst, P.M. Hellstrom Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety Regul Pept 116 2003 21 25
173. N. Geary Glucagon and the control of meal size G.P. Smith Satiation 1998 Oxford University Press From gut to brain. New York 164 197
174. J.M. Salter Metabolic effects of glucagon in the Wistar rat Am J Clin Nutr 8 1960 535 539
175. S.C. Woods, E.C. Lotter, L.D. McKay, D. Porte Jr Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons Nature 282 1979 503 505
176. N. Geary, J. Le Sauter, U. Noh Glucagon acts in the liver to control spontaneous meal size in rats Am J Physiol 264 1993 R116 R122
177. J. Le Sauter, U. Noh, N. Geary Hepatic portal infusion of glucagon antibodies increases spontaneous meal size in rats Am J Physiol 261 1991 R162 R165
178. W. Langhans, U. Zieger, E. Scharrer, N. Geary Stimulation of feeding in rats by intraperitoneal injection of antibodies to glucagon Science 218 1982 894 896
179. T.E. Adrian, A.J. Bacarese-Hamilton, H.A. Smith, P. Chohan, K.J. Manolas, S.R. Bloom Distribution and postprandial release of porcine peptide YY J Endocrinol 113 1987 11 14
180. R.G. Taylor, D.J. Beveridge, P.J. Fuller Expression of ileal glucagon and peptide tyrosine-tyrosine genes. Response to inhibition of polyamine synthesis in the presence of massive small-bowel resection Biochem J 286 1992 737 741
181. D. Grandt, M. Schimiczek, C. Beglinger, P. Layer, H. Goebell, V.E. Eysselein, J.R. Reeve Jr Two molecular forms of peptide YY (PYY) are abundant in human blood characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36 Regul Pept 51 1994 151 159
182. R. Mentlein, P. Dahms, D. Grandt, R. Kruger Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV Regul Pept 49 1993 133 144
183. D. Larhammar Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide Regul Pept 65 1996 165 174
184. E.S. Corp, L.D. Melville, D. Greenberg, J. Gibbs, G.P. Smith Effect of fourth ventricular neuropeptide Y and peptide YY on ingestive and other behaviors Am J Physiol 259 1990 R317 R323
185. R.L. Batterham, M.A. Cowley, C.J. Small, H. Herzog, M.A. Cohen, C.L. Dakin, A.M. Wren, A.E. Brynes, M.J. Low, M.A. Ghatei, R.D. Cone, S.R. Bloom Gut hormone PYY(3-36) physiologically inhibits food intake Nature 418 2002 650 654
186. E. Ekblad, F. Sundler Distribution of pancreatic polypeptide and peptide YY Peptides 23 2002 251 261
187. G.H. Greeley Jr, T. Hashimoto, M. Izukura, G. Gomez, J. Jeng, F.L. Hill, F. Lluis, J.C. Thompson A comparison of intraduodenally and intracolonically administered nutrients on the release of peptide-YY in the dog Endocrinology 125 1989 1761 1765
188. H.C. Lin, X.T. Zhao, L. Wang, H. Wong Fat-induced ileal brake in the dog depends on peptide YY Gastroenterology 110 1996 1491 1495
189. R.C. Spiller, I.F. Trotman, B.E. Higgins, M.A. Ghatei, G.K. Grimble, Y.C. Lee, S.R. Bloom, J.J. Misiewicz, D.B. Silk The ileal brake-inhibition of jejunal motility after ileal fat perfusion in man Gut 25 1984 365 374
190. Y. Anini, X. Fu-Cheng, J.C. Cuber, A. Kervran, J. Chariot, C. Roz Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat Pflugers Arch 438 1999 299 306
191. M.M. Hagan Peptide YY a key mediator of orexigenic behavior Peptides 23 2002 377 382
192. M.M. Hagan, D.E. Moss Suppression of peptide YY-induced hyperphagia by terbutaline Pharmacol Biochem Behav 46 1993 679 681
193. M. Nakajima, A. Inui, A. Teranishi, M. Miura, Y. Hirosue, M. Okita, N. Himori, S. Baba, M. Kasuga Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice J Pharmacol Exp Ther 268 1994 1010 1014
194. E. Itoh, M. Fujimiya, A. Inui Thioperamide, a histamine H3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats Biol Psychiatry 45 1999 475 481
195. J.E. Morley, A.S. Levine, M. Grace, J. Kneip Peptide YY (PYY), a potent orexigenic agent Brain Res 341 1985 200 203
196. R.L. Batterham, M.A. Cohen, S.M. Ellis, C.W. Le Roux, D.J. Withers, G.S. Frost, M.A. Ghatei, S.R. Bloom Inhibition of food intake in obese subjects by peptide YY3-36 N Engl J Med 349 2003 941 948
197. R.L. Batterham, C.W. Le Roux, M.A. Cohen, A.J. Park, S.M. Ellis, M. Patterson, G.S. Frost, M.A. Ghatei, S.R. Bloom Pancreatic polypeptide reduces appetite and food intake in humans J Clin Endocrinol Metab 88 2003 3989 3992
198. T.H. Moran, S. Knipp, U. Smedh, E.E. Ladenheim PYY(3-36) inhibits food intake and gastric emptying in monkeys Appetite 40 2003 349
199. M. Tschöp, T.R. Castañeda, H.G. Joost, C. Thöne-Reineke, S. Ortmann, S. Klaus, M.M. Bogiano, P.C. Chandler, K.D. Oswald, S.C. Benoit, R.J. Seeley, K.P. Kinzig, T.H. Moran, A.G. Beck-Sickinger, N. Koglin, R.J. Rodgers, J.E. Blundell, Y. Ishii, A.H. Beattie, P. Holch, D.B. Allison, K. Raun, K. Madsen, B.S. Wulff, C.E. Stidsen, M. Birringer, O. Kreuzer, M. Schindler, K. Arndt, K. Rudolf, M. Mark, X.Y. Deng, D.C. Withcomb, H. Halem, J. Taylor, J. Dong, R. Datta, M. Culler, S. Craney, D. Flora, D. Smiley, M.L. Heiman Physiology does gut hormone PYY(3-36) decrease food intake in rodents? Nature 430 2004 165 166
200. C. Thöne-Reineke, S. Ortman, T. Castaneda, M. Birringer, M. Tschöp Effects of peripheral administration of PYY(3-36) on energy balance in mice 2003 In Endocrine Society Philadelphia
201. R.D. Cone, M.A. Cowley, A.A. Butler, W. Fan, D.L. Marks, M.J. Low The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis Int J Obes Relat Metab Disord 25 Suppl 5 2001 S63 S67
202. N. Nonaka, S. Shioda, M.L. Niehoff, W.A. Banks Characterization of blood-brain barrier permeability to PYY3-36 in mouse (comments) J Pharmacol Exp Ther 306 2003 948 953
203. R.L. Batterham, S.R. Bloom The gut hormone peptide YY regulates appetite Ann N Y Acad Sci 994 2003 162 168
204. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
205. H. Masuzaki, Y. Ogawa, N. Sagawa, K. Hosoda, T. Matsumoto, H. Mise, H. Nishimura, Y. Yoshimasa, I. Tanaka, T. Mori, K. Nakao Nonadipose tissue production of leptin leptin as a novel placenta-derived hormone in humans Nat Med 3 1997 1029 1033
206. J. Wang, R. Liu, M. Hawkins, N. Barzilai, L. Rossetti A nutrient-sensing pathway regulates leptin gene expression in muscle and fat Nature 393 1998 684 688
207. A. Bado, S. Levasseur, S. Attoub, S. Kermorgant, J.P. Laigneau, M.N. Bortoluzzi, L. Moizo, T. Lehy, M. Guerre-Millo, Y. Le Marchand-Brustel, M.J. Lewin The stomach is a source of leptin Science 394 1998 90 93
208. S. Cinti, R.D. Matteis, C. Pico, E. Ceresi, A. Obrador, C. Maffeis, J. Oliver, A. Palou Secretory granules of endocrine and chief cells of human stomach mucosa contain leptin Int J Obes Relat Metab Disord 24 2000 789 793
209. S. Cinti, R. de Matteis, E. Ceresi, C. Pico, J. Oliver, P. Oliver, A. Palou, A. Obrador, C. Maffeis Leptin in the human stomach Gut 49 2001 155
210. I. Sobhani, A. Bado, C. Vissuzaine, M. Buyse, S. Kermorgant, J.P. Laigneau, S. Attoub, T. Lehy, D. Henin, M. Mignon, M.J. Lewin Leptin secretion and leptin receptor in the human stomach Gut 47 2000 178 183
211. C. Pico, J. Sanchez, P. Oliver, A. Palou Leptin production by the stomach is up-regulated in obese (fa/fa) Zucker rats Obes Res 10 2002 932 938
212. I. Sobhani, M. Buyse, H. Goiot, N. Weber, J.P. Laigneau, D. Henin, J.C. Soul, A. Bado Vagal stimulation rapidly increases leptin secretion in human stomach Gastroenterology 122 2002 259 263
213. R.S. Ahima, D. Prabakaran, C. Mantzoros, D. Qu, B. Lowell, E. Flier-Maratos, J.S. Flier Role of leptin in the neuroendocrine response to fasting Nature 382 1996 250 252
214. J.K. Elmquist, C.F. Elias, C.B. Saper From lesions to leptin hypothalamic control of food intake and body weight Neuron 22 1999 221 232
215. P. Tso, M. Liu, T.J. Kalogeris, A.B. Thomson The role of apolipoprotein A-IV in the regulation of food intake Annu Rev Nutr 21 2001 231 254
216. M. Liu, T. Doi, L. Shen, S.C. Woods, R.J. Seeley, S. Zheng, A. Jackman, P. Tso Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus Am J Physiol 280 2001 R1382 R1387
217. K. Fujimoto, K. Fukagawa, T. Sakata, P. Tso Suppression of food intake by apolioprotein A-IV is mediated through the central nervous system in rats J Clin Invest 91 1993 1830 1833
218. K. Fujimoto, H. Machidori, R. Iwakiri, K. Yamamoto, J. Fujisaki, T. Sakata, P. Tso Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity in rats Brain Res 608 1993 233 237
219. M. Liu, L. Shen, T. Doi, S.C. Woods, R.J. Seeley, P. Tso Neuropeptide Y and lipid increase apolipoprotein AIV gene expression in rat hypothalamus Brain Res 971 2003 232 238
220. S. Okada, D.A. York, G.A. Bray, C. Erlanson-Albertsson Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake Physiol Behav 49 1991 1185 1189
221. N.S. Shargill, S. Tsuji, G.A. Bray, C. Erlanson-Albertsson Enterostatin suppresses food intake following injection into the third ventricle of rats Brain Res 544 1991 137 140
222. J. Mei, C. Erlanson-Albertsson Effect of enterostatin given intravenously and intracerebroventricularly on high-fat feeding in rats Regul Pept 41 1992 209 218
223. S. Okada, D.A. York, G.A. Bray, J. Mei, C. Erlanson-Albertsson Differential inhibition of fat intake in two strains of rat by the peptide enterostatin Am J Physiol 262 1992 R1111 R1116
224. D.E. Cummings, J.Q. Purnell, R.S. Frayo, K. Schmidova, B.E. Wisse, D.S. Weigle A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans Diabetes 50 2001 1714 1719
225. A.M. Wren, C.J. Small, C.R. Abbott, W.S. Dhillo, L.J. Seal, M.A. Cohen, R.L. Batterham, S. Taheri, S.A. Stanley, M.A. Ghatei, S.R. Bloom Ghrelin causes hyperphagia and obesity in rats Diabetes 50 2001 2540 2547
226. A. Asakawa, A. Inui, T. Kaga, H. Yuzuriha, T. Nagata, N. Ueno, S. Makino, M. Fujimiya, A. Niijima, M.A. Fujino, M. Kasuga Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin Gastroenterology 120 2001 337 345
227. D.E. Cummings, K. Clement, J.Q. Purnell, C. Vaisse, K.E. Foster, R.S. Frayo, M.W. Schwartz, A. Basdevant, D.S. Weigle Elevated plasma ghrelin levels in Prader Willi syndrome Nat Med 8 2002 643 644
228. E.F. Adolph Urges to eat and drink in rats Am J Physiol 151 1947 110 125
229. H.D. Janowitz, M.I. Grossman Effect of variations in nutritive density of food in dogs and rats Am J Physiol 158 1949 184 193
230. S.C. Woods The eating paradox how we tolerate food Psychol Rev 98 1991 488 505
231. S.C. Woods, J.H. Strubbe The psychobiology of meals Psychon Bull Rev 1 1994 141 155
232. L.A. Campfield, F.J. Smith, Y. Guisez, R. Devos, P. Burn Recombinant mouse OB protein evidence for a peripheral signal linking adiposity and central neural networks Science 269 1995 546 549
233. R.J. Seeley, G. van Dijk, L.A. Campfield, F.J. Smith, J.A. Nelligan, S.M. Bell, D.G. Baskin, S.C. Woods, M.W. Schwartz The effect of intraventricular administration of leptin on food intake and body weight in the rat Horm Metab Res 28 1996 664 668
234. S.C. Woods, R.J. Seeley Insulin as an adiposity signal Int J Obes Relat Metab Disord 25 2001 S35 S38
235. W.A. Banks Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations Curr Pharm Des 9 2003 801 809
236. S.C. Woods, R.J. Seeley, D.G. Baskin, M.W. Schwartz Insulin and the blood-brain barrier Curr Pharm Des 9 2003 795 800
237. R.J. Seeley, T.H. Moran Principles for interpreting interactions among the multiple systems that influence food intake Am J Physiol Regul Integr Comp Physiol 283 2002 R46 R53
238. A.S. Kopin, W.F. Mathes, E.W. McBride, M. Nguyen, W. Al-Haider, F. Schmitz, S. Bonner-Weir, R. Kanarek, M. Beinborn The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight J Clin Invest 103 1999 383 391
239. D.J. Drucker Glucagon-like peptides Diabetes 47 1998 159 169
240. D.J. Drucker, R.P. Boushey, F. Wang, M.E. Hill, P.L. Brubaker, B. Yusta Biologic properties and therapeutic potential of glucagon-like peptide-2 JPEN J Parenter Enteral Nutr 23 1999 S98 S100
241. L.A. Scrocchi, T.J. Brown, N. MacLusky, P.L. Brubaker, A.B. Auerbach, A.L. Joyner, D.J. Drucker Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene Nat Med 2 1996 1254 1258
242. Y. Sun, S. Ahmed, R.G. Smith Deletion of ghrelin impairs neither growth nor appetite Mol Cell Biol 23 2003 7973 7981
243. S.C. Woods, D.B. West, L.J. Stein, L.D. McKay, E.C. Lotter, S.G. Porte, N.J. Kenney, D. Porte Jr Peptides and the control of meal size Diabetologia 20 1981 305 313
244. T.P. Vahl, D.A. D'Alessio Gut peptides in the treatment of diabetes mellitus Expert Opin Investig Drugs 13 2004 177 188
245. K. Miyawaki, Y. Yamada, N. Ban, Y. Ihara, K. Tsukiyama, H. Zhou, S. Fujimoto, A. Oku, K. Tsuda, S. Toyokuni, H. Hiai, W. Mizunoya, T. Fushiki, J.J. Holst, M. Makino, A. Tashita, Y. Kobara, Y. Tsubamoto, T. Jinnouchi, T. Jomori, Y. Seino Inhibition of gastric inhibitory polypeptide signaling prevents obesity Nat Med 8 2002 738 742
246. E.E. Mason, C. Ito Gastric bypass in obesity Surg Clin North Am 47 1967 1345 1351
247. A.J. Kremen, J.H. Linner, C.H. Nelson An experimental evaluation of the nutritional importance of proximal and distal small intestine Ann Surg 140 1954 439 448
248. E. Naslund, P.M. Hellstrom, J.G. Kral The gut and food intake an update for surgeons J Gastrointest Surg 5 2001 556 567
249. E. Naslund, P. Gryback, P.M. Hellstrom, H. Jacobsson, J.J. Holst, E. Theodorsson, L. Backman Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity Int J Obes Relat Metab Disord 21 1997 387 392
250. J.M. Kellum, J.F. Kuemmerle, T.M. O'Dorisio, P. Rayford, D. Martin, K. Engle, L. Wolf, H.J. Sugerman Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty Ann Surg 211 1990 763 771
251. P. Wilson, N.T. Welch, R.A. Hinder, M. Anselmino, M.K. Herrington, T.R. DeMeester, T.E. Adrian Abnormal plasma gut hormones in pathologic duodenogastric reflux and their response to surgery Am J Surg 165 1993 169 177
252. G.F. Adami, R. Cordera, G. Camerini, G.M. Marinari, N. Scopinaro Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion J Surg Res 113 2003 217 221
253. S.E. Greenway, F.L. Greenway III, S. Klein Effects of obesity surgery on non-insulin-dependent diabetes mellitus Arch Surg 137 2002 1109 1117
254. F. Rubino, M. Gagner Potential of surgery for curing type 2 diabetes mellitus Ann Surg 236 2002 554 559
255. H.S. Koopmans, A. Sclafani Control of body weight by lower gut signals Int J Obes 5 1981 491 495
256. H.S. Koopmans, G.L. Ferri, D.L. Sarson, J.M. Polak, S.R. Bloom The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats Physiol Behav 33 1984 601 609
257. C.N. Boozer, P.S. Choban, R.L. Atkinson Ileal transposition surgery attenuates the increased efficiency of weight gain on a high-fat diet Int J Obes 14 1990 869 878
258. D.C. Chen, J.S. Stern, R.L. Atkinson Effects of ileal transposition on food intake, dietary preference, and weight gain in Zucker obese rats Am J Physiol 258 1990 R269 R273
259. Strader ADVT, Jandacek RJ, Woods SC, D'Alessio DA, Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in the rat. Am J Physiol (in press).
260. M. Tschöp, C. Weyer, P.A. Tataranni, V. Devanarayan, E. Ravussin, M.L. Heiman Circulating ghrelin levels are decreased in human obesity Diabetes 50 2001 707 709
261. D.L. Williams, D.E. Cummings, H.J. Grill, J.M. Kaplan Meal-related ghrelin suppression requires postgastric feedback Endocrinology 144 2003 2765 2767
262. J.F.R. Overduin, D.E. Cummings Role of the duodenum and macronutrient type in prandial suppression of ghrelin NAASO Annual Meeting Obesity Research Supplement 11 2003 A21
263. D.E. Cummings, D.S. Weigle, R.S. Frayo, P.A. Breen, M.K. Ma, E.P. Dellinger, J.Q. Purnell Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery N Engl J Med 346 2002 1623 1630
264. M. Faraj, P.J. Havel, S. Phelis, D. Blank, A.D. Sniderman, K. Cianflone Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects J Clin Endocrinol Metab 88 2003 1594 1602
265. F. Leonetti, G. Silecchia, G. Iacobellis, M.C. Ribaudo, A. Zappaterreno, C. Tiberti, C.V. Iannucci, N. Perrotta, V. Bacci, M.S. Basso, N. Basso, U. Di Mario Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects J Clin Endocrinol Metab 88 2003 4227 4231
266. R. Stoeckli, R. Chanda, I. Langer, U. Keller Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass Obes Res 12 2004 346 350
267. B. Geloneze, M.A. Tambascia, V.F. Pilla, S.R. Geloneze, E.M. Repetto, J.C. Pareja Ghrelin: a gut-brain hormone: effect of gastric bypass surgery Obes Surg 13 2003 17 22
268. N.A. Tritos, E. Mun, A. Bertkau, R. Grayson, E. Maratos-Flier, A. Goldfine Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery Obes Res 11 2003 919 924
269. C. Holdstock, B.E. Engstrom, M. Ohrvall, L. Lind, M. Sundbom, F.A. Karlsson Ghrelin and adipose tissue regulatory peptides effect of gastric bypass surgery in obese humans J Clin Endocrinol Metab 88 2003 3177 3183
270. S. Meryn, D. Stein, E.W. Straus Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation Int J Obes 10 1986 37 42
271. R.H. Clements, Q.H. Gonzalez, C.I. Long, G. Wittert, H.L. Laws Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus Am Surg 70 2004 1 5
272. M. Alvarez Bartolome, M. Borque, J. Martinez-Sarmiento, E. Aparicio, C. Hernandez, L. Cabrerizo, J.A. Fernandez-Represa Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty Obes Surg 12 2002 324 327
273. E. Gianetta, S.R. Bloom, D.L. Sarson, D. Civalleri, U. Bonalumi, F. Griffanti Bartoli, D. Friedman, L. Pitton, P.L. Binda, R. Degrandi, N. Scopinaro Behavior of plasma enteroglucagon and neurotensin in obese patients subjected to biliopancreatic bypass Boll Soc Ital Biol Sper 56 1980 1915 1921
274. D.L. Sarson, N. Scopinaro, S.R. Bloom Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity Int J Obes 5 1981 471 480
275. L. Ockander, J.L. Hedenbro, J.F. Rehfeld, K. Sjolund Jejunoileal bypass changes the duodenal cholecystokinin and somatostatin cell density Obes Surg 13 2003 584 590
276. P.J. Havel Peripheral signals conveying metabolic information to the brain short-term and long-term regulation of food intake and energy homeostasis Exp Biol Med (Maywood) 226 2001 963 977